A watch-and-wait strategy for certain patients with rectal cancer who achieved clinical complete response following neoadjuvant therapy yielded high rates of rectal preservation and pelvic tumor control, according to a recent study published in JAMA Oncology.
However, the approach appeared associated with shorter survival and higher incidence of distant progression among patients with local regrowth.
“Our group previously noted that a watch-and-wait approach was safe and efficacious after clinical complete response; however, the intervals of follow-up were short and the numbers of
You may also like
Marcia Cross of 'Desperate Housewives' Opens Up on Anal Cancer
- April 21, 2019
(MedPage Today) — ActressRead more
GAP Regimen Tops Historical Data for Advanced Biliary Tract Ca
- April 20, 2019
(MedPage Today) — ResultsRead more